Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Postoperative residual neuromuscular blockade after rocuronium with spontaneous recovery, sugammadex, or neostigmine
2013-001965-17Phase 4Completed
- Sponsor
- University of Debrecen Department of Anesthesiology and Intensive Therapy
- Start
- Aug 2013
- Modality
- Small Molecules, Biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 4, randomised trial of rocuronium, Sugammadex and neostigmine (3 arms), sponsored by University of Debrecen Department of Anesthesiology and Intensive Therapy. Primary endpoint: Incidence of postoperative residual neuromuscular blockade on arrival to the postanaesthesia care unit. Started Aug 2013; status: completed.
02
Drugs
rocuroniumSugammadexneostigmine
Beyond the preview
Go deeper on 2013-001965-17.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-001965-17.